×
Alphatec Holdings EBITDA 2010-2024 | ATEC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Alphatec Holdings ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
Alphatec Holdings EBITDA 2010-2024 | ATEC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Alphatec Holdings ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$211B
Intuitive Surgical (ISRG)
$191.1B
Alcon (ALC)
$45.7B
IQVIA Holdings (IQV)
$39.8B
Edwards Lifesciences (EW)
$39.1B
IDEXX Laboratories (IDXX)
$35.5B
DexCom (DXCM)
$27.3B
Waters (WAT)
$22.8B
SONOVA HOLDING (SONVY)
$22.1B
STERIS (STE)
$21.6B
Hologic (HOLX)
$18.3B
Sysmex ADR (SSMXY)
$12.9B
Fresenius Medical Care AG KGaA (FMS)
$12.5B
Globus Medical (GMED)
$11B
Teleflex (TFX)
$9.1B
Penumbra (PEN)
$9.1B
Masimo (MASI)
$8.7B
Glaukos (GKOS)
$7.8B
PROCEPT BioRobotics (PRCT)
$5.2B
Integer Holdings (ITGR)
$4.6B
Inari Medical (NARI)
$3B
TransMedics (TMDX)
$2.9B
LivaNova (LIVN)
$2.8B
Veracyte (VCYT)
$2.8B
Nihon Kohden (NHNKY)
$2.6B
Elekta AB (EKTAY)
$2.3B
Tandem Diabetes Care (TNDM)
$2B
Integra LifeSciences Holdings (IART)
$1.9B
RxSight (RXST)
$1.8B
Pulse Biosciences (PLSE)
$1.2B